Chime Communication commits to Succinct buy-out

Author

By John Glenday, Reporter

February 1, 2012 | 1 min read

Marketing services group Chime Communications has announced that it has agreed to take a 100% stake in Succinct Communications Ltd (SCL) – a specialist in medical communications for prescription medicines.

SCL’s clients include the likes of Bayer, GE, GSK, Roche and Senofi and it will continue to operate under its existing management team led by owner directors Sean McGrath and Lisa Dodgshon.

The acquisition constitutes an attempt by Chime to diversify its own healthcare arm, OPEN Health.

Lord Bell, Chairman of Chime Communications, commented: ”As a diversified communications group we see healthcare as an attractive sector in which we wish to compete strongly. The acquisition of SCL strengthens our recently established healthcare practice OPEN Health still further.”

David Rowley, Chief Executive of OPEN Health, said: ”High science and evidence based communications is the growth sector in healthcare communications, and OPEN Health intend to build a significant practice in this area. Sean and Lisa have built a fabulous business in Succinct Communications, and I have no doubt that in partnership with OPEN Health, the company will continue its impressive growth curve.”

Trending

Industry insights

View all
Add your own content +